Saturday, December 15, 2007

Pearls for Drill.

The FDA has approved a nitroglycerin lingual 400-µg/actuation aerosol container for the acute aid of an onset or acute prophylaxis of heart disease pectoris due to coronary blood vessel disease. Each container contains 230 metered sprays. At the start of an turn, 1 or 2 metered sprays are administered under the language. A spirt may be repeated at about 5-minute intervals as needed. The bound recommended dose is 3 sprays during a menstruation of 15 minutes. The spirt may also be used prophylactically 5 to 10 minutes before engaging in activities that may precipitate an acute degeneration. Use of the sprayer is contraindicated in patients using phosphodiesterase type 5 inhibitors and those with severe fern genus, increased intracranial pressure level, or a known susceptibility to nitrates or nitrites.The FDA has approved an oral hanging preparation of delayed-release esomeprazole magnesium. The contents of the 20- and 40-mg packets are mixed with binary compound for oral, nasogastric, or gastric presidency in patients unable to drink pills.The FDA has approved a new reading for docetaxel intravenous instillment, allowing its use in assemblage with cisplatin and fluorouracil for the colligation intervention of patients with inoperable, locally advanced squamous cell carcinoma of the head and neck. The blessing was based on clinical document data viewing that the plus of docetaxel to cisplatin and fluorouracil significantly increased progression-free and boilers suit activity vs cisplatin and fluorouracil alone.

No comments: